These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15865639)

  • 21. Low dose.
    Shrivastava S; Ridker PM
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):880-1. PubMed ID: 16491634
    [No Abstract]   [Full Text] [Related]  

  • 22. Clearing the way: treating venous thromboembolism and deep vein thrombosis.
    Lambing A
    Adv Nurse Pract; 2005 Jun; 13(6):24-30; quiz 31. PubMed ID: 15984353
    [No Abstract]   [Full Text] [Related]  

  • 23. Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism?
    Sharma GK
    Arch Intern Med; 2000 Jul; 160(13):2065-6. PubMed ID: 10888989
    [No Abstract]   [Full Text] [Related]  

  • 24. Venous thromboembolism.
    Spaulding C
    J Fam Pract; 1995 Dec; 41(6):604-5. PubMed ID: 7500073
    [No Abstract]   [Full Text] [Related]  

  • 25. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of deep vein thrombosis. First choice treatments.
    Prescrire Int; 2015 Sep; 24(163):217-9. PubMed ID: 26417635
    [No Abstract]   [Full Text] [Related]  

  • 27. Thromboembolic diseases.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
    [No Abstract]   [Full Text] [Related]  

  • 28. New heparin is no heavyweight.
    Feinberg AW
    Health News; 2000 Aug; 6(8):5-6. PubMed ID: 10948870
    [No Abstract]   [Full Text] [Related]  

  • 29. [Venous thromboembolic disease].
    Sternon J
    Rev Med Brux; 1993 May; 14(5):145-51. PubMed ID: 8391712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute venous thrombosis: new directions in prophylaxis and treatment].
    Fedorov VD; Titiova MI; Ganzha PF
    Khirurgiia (Mosk); 1998; (12):60-3. PubMed ID: 9916443
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 32. The optimal long-term treatment of venous thromboembolism.
    Prandoni P
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy.
    Thomson AJ; Walker ID; Greer IA
    Lancet; 1998 Dec; 352(9144):1904. PubMed ID: 9863791
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of venous thromboembolism in cancer patients].
    Okugawa T; Tabata T; Yamada N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():645-52. PubMed ID: 15535325
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of venous thromboembolism.
    Nazario R; Delorenzo LJ; Maguire AG
    Cardiol Rev; 2002; 10(4):249-59. PubMed ID: 12144736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Drugs; 1996 Jul; 52(1):71-92. PubMed ID: 8799686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-molecular-weight heparin for treating venous thromboembolism.
    Mahoney MS; Kahn M
    Ann Intern Med; 1999 Jan; 130(1):77-8. PubMed ID: 9890863
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hematochezia during anticoagulation. Pulmonary embolism as a life saver?].
    Stiefelhagen P
    MMW Fortschr Med; 2013 Dec; 155(21-22):30. PubMed ID: 24724260
    [No Abstract]   [Full Text] [Related]  

  • 39. Changing paradigms in the management of venous thromboembolism.
    Weitz JI
    Am Heart Hosp J; 2006; 4(2):135-41. PubMed ID: 16687960
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1024-5. PubMed ID: 11484301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.